RPL27A
Basic information
Region (hg38): 11:8682788-8714759
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RPL27A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 3 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 3 | 0 | 0 |
Variants in RPL27A
This is a list of pathogenic ClinVar variants found in the RPL27A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-8684834-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
11-8684852-A-G | not specified | Uncertain significance (Jan 02, 2024) | ||
11-8684861-G-T | not specified | Uncertain significance (Jun 18, 2021) | ||
11-8695456-C-T | Benign (Feb 28, 2019) | |||
11-8696435-C-T | not specified | Uncertain significance (Dec 18, 2023) | ||
11-8696458-T-G | not specified | Uncertain significance (Jun 02, 2023) | ||
11-8696538-G-A | not specified | Uncertain significance (May 23, 2023) | ||
11-8696549-C-T | not specified | Uncertain significance (Sep 09, 2021) | ||
11-8696643-C-T | not specified | Uncertain significance (Feb 22, 2024) | ||
11-8697528-C-T | not specified | Uncertain significance (Sep 15, 2021) | ||
11-8697564-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
11-8697620-G-A | not specified | Uncertain significance (Nov 20, 2023) | ||
11-8699217-T-G | not specified | Uncertain significance (Nov 09, 2021) | ||
11-8699279-G-A | Likely benign (Jun 20, 2018) | |||
11-8699369-G-C | not specified | Uncertain significance (Dec 20, 2023) | ||
11-8702644-A-G | Likely benign (Mar 01, 2023) | |||
11-8702645-C-T | not specified | Uncertain significance (Dec 14, 2021) | ||
11-8702647-C-T | not specified | Uncertain significance (May 17, 2023) | ||
11-8702689-C-G | not specified | Uncertain significance (May 24, 2023) | ||
11-8707189-C-T | Benign (Dec 31, 2019) | |||
11-8707207-G-A | not specified | Uncertain significance (Feb 13, 2024) | ||
11-8707806-G-A | not specified | Uncertain significance (Apr 17, 2023) | ||
11-8707838-G-A | not specified | Uncertain significance (Jun 29, 2022) | ||
11-8707850-C-T | not specified | Uncertain significance (May 24, 2023) | ||
11-8708304-T-G | Benign (May 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RPL27A | protein_coding | protein_coding | ENST00000314138 | 5 | 32349 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.911 | 0.0887 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.929 | 62 | 86.3 | 0.719 | 0.00000470 | 968 |
Missense in Polyphen | 0 | 10.402 | 0 | 144 | ||
Synonymous | -0.603 | 36 | 31.7 | 1.14 | 0.00000167 | 284 |
Loss of Function | 2.58 | 0 | 7.78 | 0.00 | 4.13e-7 | 93 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Ribosome - Homo sapiens (human);Cytoplasmic Ribosomal Proteins;SRP-dependent cotranslational protein targeting to membrane;Eukaryotic Translation Initiation;Eukaryotic Translation Termination;Translation;Selenocysteine synthesis;Metabolism of proteins;Metabolism of amino acids and derivatives;Metabolism of RNA;Formation of a pool of free 40S subunits;Metabolism;Nonsense-Mediated Decay (NMD);Selenoamino acid metabolism;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);L13a-mediated translational silencing of Ceruloplasmin expression;Peptide chain elongation;Eukaryotic Translation Elongation;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation
(Consensus)
Recessive Scores
- pRec
- 0.169
Intolerance Scores
- loftool
- rvis_EVS
- 0.08
- rvis_percentile_EVS
- 59.43
Haploinsufficiency Scores
- pHI
- 0.967
- hipred
- Y
- hipred_score
- 0.802
- ghis
- 0.641
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.870
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rpl27a
- Phenotype
- immune system phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; pigmentation phenotype; neoplasm; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane
- Cellular component
- endoplasmic reticulum;cytosol;membrane;cytosolic large ribosomal subunit
- Molecular function
- RNA binding;structural constituent of ribosome;protein binding